Fan QH, Long S, Wu XK, Fang Q. Management of a rare giant cell tumor of the distal fibula: A case report. World J Clin Cases 2023; 11(2): 394-400 [PMID: 36686354 DOI: 10.12998/wjcc.v11.i2.394]
Corresponding Author of This Article
Qing-Hong Fan, MM, Associate Chief Physician, Surgeon, Department of Orthopaedics, The Second Affiliated Hospital of Zunyi Medical University, Xinlong Avenue, Xinpu District, Zunyi 563000, Guizhou Province, China. fanqh110@126.com
Research Domain of This Article
Orthopedics
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Jan 16, 2023; 11(2): 394-400 Published online Jan 16, 2023. doi: 10.12998/wjcc.v11.i2.394
Management of a rare giant cell tumor of the distal fibula: A case report
Qing-Hong Fan, Shan Long, Xing-Kai Wu, Qin Fang
Qing-Hong Fan, Xing-Kai Wu, Qin Fang, Department of Orthopaedics, The Second Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China
Shan Long, Department of Neonatology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China
Author contributions: Fan QH and Long S wrote the manuscript and prepared the figures; Wu XK and Fang Q contributed to conceiving and designing the study and critically revised the manuscript; All authors read and approved the final manuscript.
Informed consent statement: The guardian of patient provided written informed consent to publish this case report and any accompanying images.
Conflict-of-interest statement: The authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Qing-Hong Fan, MM, Associate Chief Physician, Surgeon, Department of Orthopaedics, The Second Affiliated Hospital of Zunyi Medical University, Xinlong Avenue, Xinpu District, Zunyi 563000, Guizhou Province, China. fanqh110@126.com
Received: May 13, 2022 Peer-review started: May 13, 2022 First decision: July 29, 2022 Revised: August 7, 2022 Accepted: October 24, 2022 Article in press: October 24, 2022 Published online: January 16, 2023 Processing time: 244 Days and 0.9 Hours
Abstract
BACKGROUND
Aggressive giant cell tumor of the distal fibula is so rare that no consensus on a surgical strategy has been reached. Thus, an appropriate treatment strategy is still important to discuss.
CASE SUMMARY
A 61-year-old man who had been experiencing progressive swelling of the left lateral malleolus accompanied by pain for half a year was presented at our hospital. He had never been treated prior to coming to our hospital. Preoperative imaging revealed a 10 cm × 6 cm mass located in the body of the distal fibula. Pathological biopsies confirmed it was a giant cell tumor. Preoperative examination revealed he had dilated cardiomyopathy with class 3 cardiac function. The cardiologist and anesthesiologist determined that he could tolerate the operation, but the operation should be as short and minimally invasive as possible. With the patient’s consent, we performed a tibiotalar fusion and followed up with him for 2 years, finding no recurrence and a satisfactory recovery.
CONCLUSION
Tibial talus fusion is an effective method for the treatment of distal fibula tumors.
Core Tip: Giant cell tumor of the distal fibula is rare, and tibiotalus fusion has not been reported in the treatment of Campanacci III giant cell tumor of the fibula. In this study, the tibial talus joint was fused with three screws, and the follow-up for 2 years showed satisfactory efficacy and no recurrence.
